Loading company…
Syngoi Technologies produces optimized linear synthetic DNA for biotechnology and pharmaceutical research.
Syngoi Technologies produces synthetic DNA for gene editing, synthetic biology and biopharmaceutical development. Its customers include research institutions and biotechnology companies. Founded in 2021, the company is based in Spain. In January 2026, Artis BioSolutions, a portfolio company of Oak HC/FT, agreed to acquire it from Buenavista Equity Partners; financial terms were not disclosed.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in